Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN269501 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Protein Inhibitor of Activated STAT, 4 (PIAS4) antibody
- Antibody type
- Polyclonal
- Description
- Protein G purified
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 0.1 mg
- Storage
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references DNA ploidy cytometry testing for cervical cancer screening in China (DNACIC Trial): a prospective randomized, controlled trial.
Developmental control of sumoylation pathway proteins in mouse male germ cells.
MUC1 expression is repressed by protein inhibitor of activated signal transducer and activator of transcription-y.
The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.
SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Convergence of interferon-gamma and progesterone signaling pathways in human endometrium: role of PIASy (protein inhibitor of activated signal transducer and activator of transcription-y).
Tong H, Shen R, Wang Z, Kan Y, Wang Y, Li F, Wang F, Yang J, Guo X, Mass Cervical Cancer Screening Regimen Group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Oct 15;15(20):6438-45
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Oct 15;15(20):6438-45
Developmental control of sumoylation pathway proteins in mouse male germ cells.
La Salle S, Sun F, Zhang XD, Matunis MJ, Handel MA
Developmental biology 2008 Sep 1;321(1):227-37
Developmental biology 2008 Sep 1;321(1):227-37
MUC1 expression is repressed by protein inhibitor of activated signal transducer and activator of transcription-y.
Brayman MJ, Dharmaraj N, Lagow E, Carson DD
Molecular endocrinology (Baltimore, Md.) 2007 Nov;21(11):2725-37
Molecular endocrinology (Baltimore, Md.) 2007 Nov;21(11):2725-37
The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.
Albor A, El-Hizawi S, Horn EJ, Laederich M, Frosk P, Wrogemann K, Kulesz-Martin M
The Journal of biological chemistry 2006 Sep 1;281(35):25850-66
The Journal of biological chemistry 2006 Sep 1;281(35):25850-66
SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Ihara M, Yamamoto H, Kikuchi A
Molecular and cellular biology 2005 May;25(9):3506-18
Molecular and cellular biology 2005 May;25(9):3506-18
Convergence of interferon-gamma and progesterone signaling pathways in human endometrium: role of PIASy (protein inhibitor of activated signal transducer and activator of transcription-y).
Zoumpoulidou G, Jones MC, Fernandez de Mattos S, Francis JM, Fusi L, Lee YS, Christian M, Varshochi R, Lam EW, Brosens JJ
Molecular endocrinology (Baltimore, Md.) 2004 Aug;18(8):1988-99
Molecular endocrinology (Baltimore, Md.) 2004 Aug;18(8):1988-99
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB